4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-18-014852
Chief Financial Officer sold 1,104 shares at $8.25 ($9,108)
- Chief Financial Officer acquired 1,104 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-03-13 | Option exercise | +1,104 | $4.69 | $5,178 | 251,174 | D |
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-03-13 | Sale | −1,104 | $8.25 | $9,108 | 250,070 | D |
| Derivatives | |||||||
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-03-13 | Option exercise · Stock Option (Right to Buy) | −1,104 | 36,096 | D | ||
| Open-market sales · 1,104 sh · avg $8.25 · $9,108 | |||||||
Loading xslF345X03/tv488571_4.xml…